Geode Capital Management, LLC Sc Pharmaceuticals Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 643,342 shares of SCPH stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

643,342

Previous 581,760 10.59%

Holding current value

$2.25 Million

Previous $2.53 Million 15.93%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.12 - $5.51 $253,717 - $339,316	61,582 Added 10.59%	643,342 $2.93 Million
Q2 2024 Aug 09, 2024	BUY	$3.51 - $5.21 $140,108 - $207,967	39,917 Added 7.37%	581,760 $2.53 Million
Q1 2024 May 13, 2024	BUY	$4.86 - $6.39 $19,901 - $26,167	4,095 Added 0.76%	541,843 $2.72 Million
Q4 2023 Feb 13, 2024	BUY	$4.7 - $6.63 $121,856 - $171,896	25,927 Added 5.07%	537,748 $3.37 Million
Q3 2023 Nov 13, 2023	BUY	$7.0 - $9.82 $462,749 - $649,170	66,107 Added 14.83%	511,821 $3.64 Million
Q2 2023 Aug 11, 2023	BUY	$8.94 - $11.74 $2.45 Million - $3.22 Million	274,270 Added 159.98%	445,714 $4.54 Million
Q1 2023 May 15, 2023	BUY	$5.59 - $9.47 $416,583 - $705,732	74,523 Added 76.89%	171,444 $1.55 Million
Q4 2022 Feb 13, 2023	BUY	$4.02 - $7.53 $47,178 - $88,372	11,736 Added 13.78%	96,921 $694,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.52 $29,617 - $43,103	6,611 Added 8.41%	85,185 $555,000
Q2 2022 Aug 12, 2022	BUY	$4.3 - $6.48 $40,084 - $60,406	9,322 Added 13.46%	78,574 $378,000
Q1 2022 May 13, 2022	SELL	$3.9 - $6.11 $7,632 - $11,957	-1,957 Reduced 2.75%	69,252 $393,000
Q4 2021 Feb 11, 2022	SELL	$3.88 - $6.9 $54 - $96	-14 Reduced 0.02%	71,209 $357,000
Q3 2021 Nov 12, 2021	BUY	$4.93 - $7.15 $23,407 - $33,948	4,748 Added 7.14%	71,223 $473,000
Q2 2021 Aug 13, 2021	SELL	$5.19 - $7.38 $164,029 - $233,244	-31,605 Reduced 32.22%	66,475 $406,000
Q1 2021 May 12, 2021	BUY	$5.65 - $7.66 $37,064 - $50,249	6,560 Added 7.17%	98,080 $652,000
Q4 2020 Feb 12, 2021	BUY	$5.17 - $9.41 $32,431 - $59,028	6,273 Added 7.36%	91,520 $484,000
Q3 2020 Nov 13, 2020	BUY	$7.12 - $8.86 $71,164 - $88,555	9,995 Added 13.28%	85,247 $635,000
Q2 2020 Aug 13, 2020	BUY	$7.01 - $10.96 $310,010 - $484,695	44,224 Added 142.53%	75,252 $553,000
Q4 2019 Feb 13, 2020	SELL	$4.1 - $6.21 $6,785 - $10,277	-1,655 Reduced 5.06%	31,028 $175,000
Q2 2019 Aug 14, 2019	SELL	$2.48 - $3.76 $55,452 - $84,073	-22,360 Reduced 40.62%	32,683 $104,000
Q1 2019 May 14, 2019	BUY	$2.84 - $4.18 $8,869 - $13,054	3,123 Added 6.02%	55,043 $165,000
Q4 2018 Feb 13, 2019	BUY	$3.76 - $5.61 $6,147 - $9,172	1,635 Added 3.25%	51,920 $195,000
Q3 2018 Nov 13, 2018	BUY	$4.22 - $6.03 $14,702 - $21,008	3,484 Added 7.44%	50,285 $295,000
Q2 2018 Aug 14, 2018	BUY	$5.53 - $15.4 $35,132 - $97,836	6,353 Added 15.71%	46,801 $264,000
Q1 2018 May 15, 2018	BUY	$11.62 - $17.32 $470,005 - $700,559	40,448 New	40,448 $501,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

37.1M

Call Options Held

110K

Put Options Held

12.1K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $95.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Sc Pharmaceuticals Inc. Transaction History